SCM
Soleus Capital Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.98M | Hold |
6,978,942
| – | – | 0.66% | 38 |
|
|
2025
Q1 | $11.2M | Hold |
6,978,942
| – | – | 0.8% | 32 |
|
|
2024
Q4 | $25.1M | Buy |
6,978,942
+374,946
| +6% | +$1.35M | 1.58% | 19 |
|
|
2024
Q3 | $37.6M | Buy |
6,603,996
+2,552,000
| +63% | +$14.5M | 2.91% | 7 |
|
|
2024
Q2 | $18.7M | Buy |
4,051,996
+1,593,000
| +65% | +$7.36M | 1.65% | 21 |
|
|
2024
Q1 | $20.1M | Buy |
2,458,996
+623,000
| +34% | +$5.09M | 1.49% | 17 |
|
|
2023
Q4 | $10.4M | Sell |
1,835,996
-856,024
| -32% | -$4.84M | 1.15% | 28 |
|
|
2023
Q3 | $5.01M | Hold |
2,692,020
| – | – | 0.46% | 55 |
|
|
2023
Q2 | $7.4M | Buy |
2,692,020
+305,000
| +13% | +$839K | 0.82% | 37 |
|
|
2023
Q1 | $7.5M | Sell |
2,387,020
-53,823
| -2% | -$169K | 0.78% | 37 |
|
|
2022
Q4 | $14.4M | Buy |
2,440,843
+999,330
| +69% | +$5.9M | 2.07% | 15 |
|
|
2022
Q3 | $12.6M | Buy |
1,441,513
+1,158,873
| +410% | +$10.2M | 1.72% | 18 |
|
|
2022
Q2 | $2.13M | Buy |
282,640
+115,904
| +70% | +$874K | 0.33% | 57 |
|
|
2022
Q1 | $4.05M | Sell |
166,736
-394,386
| -70% | -$9.57M | 0.52% | 42 |
|
|
2021
Q4 | $18.1M | Sell |
561,122
-189,511
| -25% | -$6.1M | 1.81% | 19 |
|
|
2021
Q3 | $33.5M | Sell |
750,633
-120,125
| -14% | -$5.37M | 5.23% | 2 |
|
|
2021
Q2 | $32.9M | Buy |
870,758
+406,690
| +88% | +$15.4M | 5.07% | 3 |
|
|
2021
Q1 | $17.2M | Buy |
464,068
+195,520
| +73% | +$7.23M | 3.09% | 6 |
|
|
2020
Q4 | $8.9M | Buy |
+268,548
| New | +$8.9M | 1.17% | 7 |
|